Cármen Jerónimo
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics 35
- Cancer-related molecular mechanisms research 35
- Molecular Biology top 0.5%
- Epigenetics and DNA Methylation 139
- Cancer-related gene regulation 42
- RNA modifications and cancer 29
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research 57
- Oncology top 2%
- Surgery top 2%
- Bladder and Urothelial Cancer Treatments 35
- Testicular diseases and treatments 29
- Co-authors
- Rui HenriqueJorge OliveiraDavid SidranskyManuel R. TeixeiraJoão LoboFranclim R. RibeiroVera L. CostaCarlos Lopes
- Journals
- Cancers (28 papers)Clinical Epigenetics (13 papers)International Journal of Molecular Sciences (12 papers)
- Partner nations
- PortugalUnited StatesUnited Kingdom
In The Last Decade
Cármen Jerónimo
308 papers receiving 11.2k citations
Peers
Comparison fields: 5 of 161
- Cancer Research 3.6k
- Molecular Biology 8.3k
- Pulmonary and Respiratory Medicine 2.8k
- Oncology 1.4k
- Surgery 1.6k
Countries citing papers authored by Cármen Jerónimo
This map shows the geographic impact of Cármen Jerónimo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cármen Jerónimo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cármen Jerónimo more than expected).
Fields of papers citing papers by Cármen Jerónimo
This network shows the impact of papers produced by Cármen Jerónimo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cármen Jerónimo. The network helps show where Cármen Jerónimo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cármen Jerónimo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 1 | |
| 9 | 2021 | 20 | |
| 10 | 2021 | 31 | |
| 11 | 2021 | 27 | |
| 12 | 2021 | 20 | |
| 13 | 2020 | 136 | |
| 14 | 2020 | 29 | |
| 15 | 2020 | 23 | |
| 16 | 2018 | 57 | |
| 17 | 2011 | 70 | |
| 18 | 2010 | 139 | |
| 19 | 2008 | 115 | |
| 20 | 2004 | 184 |
About Cármen Jerónimo
Cármen Jerónimo is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 324 papers that have together received 11.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (139 papers), Prostate Cancer Treatment and Research (57 papers), Cancer-related gene regulation (42 papers), Cancer Genomics and Diagnostics (35 papers), Cancer-related molecular mechanisms research (35 papers), Bladder and Urothelial Cancer Treatments (35 papers), Testicular diseases and treatments (29 papers) and RNA modifications and cancer (29 papers). The work is most often cited by research in Cancer Research (3.6k citations), Molecular Biology (8.3k citations) and Pulmonary and Respiratory Medicine (2.8k citations). Cármen Jerónimo has collaborated with scholars based in Portugal, United States and United Kingdom. Frequent co-authors include Rui Henrique, Jorge Oliveira, David Sidransky, Manuel R. Teixeira, João Lobo, Franclim R. Ribeiro, Vera L. Costa, Carlos Lopes, Márcia Carvalho and Mohammad Obaidul Hoque. Their work appears in journals such as Cancers, Clinical Epigenetics, International Journal of Molecular Sciences, Clinical Cancer Research and Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.